Enhancement of human immunodeficiency virus (HIV)-specific CD4+ and CD8+ cytotoxic T-lymphocyte activities in HIV-infected asymptomatic patients given recombinant gp160 vaccine.

Source:http://linkedlifedata.com/resource/pubmed/id/1360665

Proc. Natl. Acad. Sci. U.S.A. 1992 Dec 1 89 23 11204-8

Download in:

View as

Triples

General Info

PMID
1360665